Jeffrey Barrett
Chief Tech/Sci/R&D Officer chez NIGHTINGALE HEALTH OYJ
Fortune : 9 394 $ au 31/03/2024
Profil
Jeffrey Barrett is currently the Chief Scientific Officer at Nightingale Health Oyj since 2021.
Prior to this, he worked as the Director and Chief Scientific Officer at Genomics Plc.
He obtained a doctorate degree from the University of Oxford.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 8 364 ( 0,02% ) | 9 394 $ | 31/03/2024 |
Postes actifs de Jeffrey Barrett
| Sociétés | Poste | Début |
|---|---|---|
| NIGHTINGALE HEALTH OYJ | Chief Tech/Sci/R&D Officer | 27/09/2021 |
Anciens postes connus de Jeffrey Barrett
| Sociétés | Poste | Fin |
|---|---|---|
Genomics Plc
 Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Formation de Jeffrey Barrett
| University of Oxford | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NIGHTINGALE HEALTH OYJ | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Genomics Plc
Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Health Technology |
